US DoJ Won’t Prosecute Many Self-Reported FCPA Violations
Executive Summary
Revisions to DoJ guidelines will let companies off the hook for self-reported overseas bribery charges in many cases. But whether or not to come forward remains a tricky decision.
You may also be interested in...
International Corruption Uncovered: Fresenius Will Pay $231M To Settle Charges Of Bribery, Sloppy Bookkeeping
Fresenius Medical Care has agreed to pay $231m to resolve reports of overseas bribery. The US Department of Justice says the dialysis giant paid bribes to health and government officials in Angola and Saudi Arabia, and failed to keep accurate financial records in Angola, Saudi Arabia, Morocco, Spain, Turkey, and several countries in West Africa.
Sanofi FCPA Settlement Follows Drought In Pharma Foreign Bribery Cases
Sanofi agrees to pay $25.2m to resolve charges its Kazakhstan and Middle East subsidiaries paid bribes to win business; last pharma settlements were in 2016.
Foreign Corrupt Practices Act: Device Industry Under Scrutiny
Federal prosecutors have begun targeting medical device companies in Foreign Corrupt Practices Act investigations